ESC Premium Access

Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)

Event: ESC CONGRESS 2019
Topic: Acute Coronary Syndromes
Session type: Satellite Symposium
Supported by an unrestricted educational grant from AstraZeneca
Date: 1 September 2019
Time: 13:00 - 14:00

Congress Session

6 presentations in this session

Welcome and Introduction

Speaker: Professor L. Wallentin (Uppsala, SE)
Thumbnail

Manipulating the platelet - Successes and failures

Speaker: Professor R. Storey (Sheffield, GB)
Thumbnail

Changing clinical outcomes with more intensive platelet inhibition

Speaker: Professor C. Cannon (Boston, US)
Thumbnail

Effects in various clinical settings, patient subsets and healthcare realities

Speaker: Professor S. James (Uppsala, SE)
Thumbnail

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?

Speaker: Professor L. Wallentin (Uppsala, SE)
Speaker: Professor R. Storey (Sheffield, GB)
Speaker: Professor C. Cannon (Boston, US)
Speaker: Professor S. James (Uppsala, SE)
Speaker: Professor R. Mehran (New York, US)
Thumbnail

Summary and close

Speaker: Professor R. Mehran (New York, US)
Thumbnail

10 speakers from this session

Professor Lars Wallentin

Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala (Sweden)
14 presentations
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
34 presentations
0 follower

Professor Lars Wallentin

Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala (Sweden)
14 presentations
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
34 presentations
0 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
32 presentations
1 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
32 presentations
1 follower

This platform is supported by

logo Novo Nordisk